Evidence map›Paper›PMID 32874083›Full record

ArticleEthiopian journal of health sciences2020

Seroprevalence and Trend of HBV, HCV, and HIV Infections among Blood Donors of Fars Province, Iran (2006-2018).

Mojtaba Azadbakht, Masoud Torabi Ardakani, Marziyeh Delirakbariazar, Leila Kasraian, Azad Khaledi, Hossein Foruozandeh, Alireza Salah, Fahimeh Maleki, Mohsen Eshraghi

Open access · diamondAbstract read
In one paragraph

Article in Ethiopian journal of health sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Mojtaba AzadbakhtBlood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iran.
Masoud Torabi ArdakaniBlood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iran.
Marziyeh DelirakbariazarTabriz University of Medical Sciences, Iran.
Leila KasraianBlood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iran.
Azad KhalediDepartment of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Iran.
Hossein ForuozandehCellular and Molecular Research Center, Gerash University of Medical Sciences, Iran.
Alireza SalahBlood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iran.
Fahimeh MalekiBlood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iran.
Mohsen EshraghiDepartment of Thoracic Surgery, Qom University of Medical Sciences, Iran.
High Institute for Education and Research in Transfusion Medicine · IRGerash University of Medical Sciences · IRInfectious Disease Research Institute · USQom University of Medical Science and Health Services · IRTabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlood transfusion is a life-saving procedure; millions of lives are saved each year. However, blood transfusions are associated with certain risks that can lead to adverse consequences. This study aimed to survey the prevalence and trend of hepatitis B virus (HBV), hepatitis C virus (HCV), and Human immunodeficiency virus (HIV) among blood donors of Fars province, Iran (2006-2018).

methodsThis retrospective cross-sectional study was conducted by reviewing the records of the blood transfusion organization of Fars province. A total of 1952478 blood units were screened for transfusion-transmitted infections (TTIs). Then, data were entered into SPSS software (Negare. version 25). Chi-square test was used to compare the sof TTIs among blood donors. Chisquare test for trend was used to analyze the variations in trends of TTIs during this period. Finally, p-values less than 0.05 were considered statistically significant. GraphPad Prism software was used for the depiction of the graphs.

resultsAmong the 1952478 blood donations within the 13-years, 4479(0.229 %) of donors were HBsAg, HCV Ab, and HIV Ag-Ab positive. The seroprevalence of HBV, HCV, and HIV was 2684(0.137%), 1703(0.087 %), and 92(0.0047%), respectively.

conclusionThe current study showed that the overall prevalence of TTIs among blood donors was low and had a descending trend over the years of study.

Indexed as

AdultAntibodies, ViralBlood DonorsCross-Sectional StudiesFemaleHepacivirusHepatitis BHepatitis B virusHepatitis CHIVHIV InfectionsHumansIranMaleMiddle AgedPrevalenceAntibodies, ViralBlood transfusionhepatitis B virusHIVHIV Seroprevalence

Identifiers

PMID32874083
PMCPMC7445945
OpenAlexW3035790053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.